diaTribe Musings:Obesity Medications in People with Diabetes: Nutrition and Lifestyle Have a Role

Live Broadcast from October 23, 2024
Type 2 Diabetes medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) can produce dramatic weight loss in addition to improving glycemic control. This is good news as the long-term health benefits of living at a healthier weight can be immense. How do these drugs work, what are their side effects and how much weight can people lose and keep off? As our eating changes, how can we make sure our nutritional needs are still met and what role should physical activity play? What are the potential impacts on our emotional health and the stigma that surrounds both diabetes and obesity?
This panel features experts in diabetes and obesity medicine, nutrition and exercise to learn how you might best benefit from these new opportunities and achieve your long-term health goals.
Speakers: Lorena Drago, MS, RDN, CDN CDCES; Dr. Lisa Neff, MD, MS, Eli Lilly and Company; Dr. John Jakicic, MS, PhD, University of Kansas Medical Center; moderated by Dr. Kelly Brownell, PhD, World Food Policy Center at Duke University
This Musings Panel was made possible with the support of
Gold: Abbott, Dexcom, Medtronic, Tandem Diabetes Care
Silver: Lilly, Novo Nordisk, Vertex